107 related articles for article (PubMed ID: 7828644)
1. Antinociceptive effect of systemic kelatorphan, in mononeuropathic rats, involves different opioid receptor types.
Lee SH; Kayser V; Guilbaud G
Eur J Pharmacol; 1994 Oct; 264(1):61-7. PubMed ID: 7828644
[TBL] [Abstract][Full Text] [Related]
2. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats.
Catheline G; Guilbaud G; Kayser V
Eur J Pharmacol; 1998 Sep; 357(2-3):171-8. PubMed ID: 9797033
[TBL] [Abstract][Full Text] [Related]
3. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors.
Catheline G; Kayser V; Guilbaud G
Eur J Pharmacol; 1996 Nov; 315(2):135-43. PubMed ID: 8960876
[TBL] [Abstract][Full Text] [Related]
4. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain.
Desmeules JA; Kayser V; Guilbaud G
Pain; 1993 Jun; 53(3):277-285. PubMed ID: 8394563
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy.
Kayser V; Lee SH; Guilbaud G
Neuroscience; 1995 Jan; 64(2):537-45. PubMed ID: 7700537
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of specific delta and kappa opioid receptor antagonists on the bidirectional dose-dependent effect of systemic naloxone in arthritic rats, an experimental model of persistent pain.
Cattaneo I; Kayser V; Guilbaud G
Brain Res; 1993 Oct; 623(2):201-7. PubMed ID: 8221101
[TBL] [Abstract][Full Text] [Related]
8. Potent antinociceptive effects of kelatorphan (a highly efficient inhibitor of multiple enkephalin-degrading enzymes) systemically administered in normal and arthritic rats.
Kayser V; Fournie-Zaluski MC; Guilbaud G; Roques BP
Brain Res; 1989 Sep; 497(1):94-101. PubMed ID: 2790459
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy.
Keïta H; Kayser V; Guilbaud G
Eur J Pharmacol; 1995 Apr; 277(2-3):275-80. PubMed ID: 7493620
[TBL] [Abstract][Full Text] [Related]
10. The antinociceptive activity of kappa- but not delta-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats.
Catheline G; Kayser V; Idänpään-Heikkilä JJ; Guilbaud G
Eur J Pharmacol; 1996 Dec; 318(2-3):273-81. PubMed ID: 9016915
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effect of (S)-N-desmethyl trimebutine against a mechanical stimulus in a rat model of peripheral neuropathy.
Kayser V; Christensen D; Guilbaud G; Roman F
Life Sci; 2000; 66(5):433-9. PubMed ID: 10670831
[TBL] [Abstract][Full Text] [Related]
12. Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats.
Lee SH; Kayser V; Desmeules J; Guilbaud G
Pain; 1994 May; 57(2):233-240. PubMed ID: 8090518
[TBL] [Abstract][Full Text] [Related]
13. Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration.
Boudinot E; Morin-Surun M; Foutz AS; Fournié-Zaluski M; Roques BP; Denavit-Saubié M
Pain; 2001 Feb; 90(1-2):7-13. PubMed ID: 11166965
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effect of systemic PC 12, a prodrug mixed inhibitor of enkephalin-degrading enzymes, in normal and arthritic rats.
Perrot S; Kayser V; Fournié-Zaluski MC; Roques BP; Guilbaud G
Eur J Pharmacol; 1993 Sep; 241(1):129-33. PubMed ID: 7901035
[TBL] [Abstract][Full Text] [Related]
15. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
16. Mu but not delta and kappa opioid receptor involvement in ventrolateral orbital cortex opioid-evoked antinociception in formalin test rats.
Xie YF; Wang J; Huo FQ; Jia H; Tang JS
Neuroscience; 2004; 126(3):717-26. PubMed ID: 15183520
[TBL] [Abstract][Full Text] [Related]
17. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
Hamurtekin E; Gurun MS
Brain Res; 2006 Oct; 1117(1):92-100. PubMed ID: 16942753
[TBL] [Abstract][Full Text] [Related]
18. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat.
Zhao M; Wang JY; Jia H; Tang JS
Neuroscience; 2007 Feb; 144(4):1486-94. PubMed ID: 17184926
[TBL] [Abstract][Full Text] [Related]
19. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
20. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone.
Crain SM; Shen KF
Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
